Cite
HARVARD Citation
Ribes, D. et al. (n.d.). Bendamustine plus rituximab for indolent B‐cell lymphoma of renal significance. American journal of hematology. 93 (3), pp. 356-362. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ribes, D. et al. (n.d.). Bendamustine plus rituximab for indolent B‐cell lymphoma of renal significance. American journal of hematology. 93 (3), pp. 356-362. [Online].